Archive for April, 2017

  • Pareto Securities has notified Isofol Medical AB (publ) that stabilisation measures regarding the Company’s shares have been taken

    In connection with the offering to acquire newly issued shares in Isofol and the listing on Nasdaq First North Premier…

    by
  • Pareto Securities has notified Isofol Medical AB that stabilisation measures regarding the Company’s shares have been taken

    For a complete press release follow the link http://isofol.se/en/ipo/  For additional information, please contact: Anders Rabbe, Managing Director, Isofol Mob: +46 70…

    by
  • aside

    Isofol has successfully completed the ISO-MTX-003 study in which Modufolin® is evaluated as rescue therapy

    Isofol Medical AB announced today that the study ISO-MTX-003 evaluating Modufolin® as rescue therapy (after two cycles of HDMTX treatment)…

    by
  • Isofol has successfully completed the ISO-MTX-003 study in which Modufolin® is evaluated as rescue therapy

    Isofol Medical AB announced today that the study ISO-MTX-003 evaluating Modufolin® as rescue therapy (after two cycles of HDMTX treatment)…

    by
  • Isofol’s largest shareholder and co-founder acquires shares in the company

    Isofol Medical AB (publ) announces today that its largest shareholder and co-founder, Bengt Gustavsson, now acquired circa 16 000 shares…

    by
  • Isofol’s Chairman of the Board acquires shares in the company

    Isofol Medical AB (publ) announces that its Chairman of the Board, Jan-Eric Österlund, now acquired 15,000 shares in Isofol to…

    by
  • aside

    Isofol Medical announces the outcome of the Offering – trading on Nasdaq First North Premier commences today

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA,…

    by